Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

Epilepsy, a common multifactorial neurological disease, affects about 69 million people worldwide constituting nearly 1% of the world population. Despite decades of extensive research on understanding its underlying mechanism and developing the pharmacological treatment, very little is known about t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawat, Chitra, Kukal, Samiksha, Dahiya, Ujjwal Ranjan, Kukreti, Ritushree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822425/
https://www.ncbi.nlm.nih.gov/pubmed/31666079
http://dx.doi.org/10.1186/s12974-019-1592-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822425/
https://www.ncbi.nlm.nih.gov/pubmed/31666079
http://dx.doi.org/10.1186/s12974-019-1592-3

Ejemplares similares